Abstract 5387: Discovery of plasma protein biomarkers associated with overall survival in R/R DLBCL patients treated with loncastuximab tesirine
Year: 2023
Type: conference-abstract
Source: Cancer Research
Institutions: Freenome (United States), Adc Therapeutics (Switzerland)
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4380029974
